Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways
(Q36138183)
scientific article
scientific article
Language:
Current Data About
Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways